Sanofi to Invest $500 Million in Diabetes

Alphabet’s Verily partners with drugmaker Sanofi on a roughly $500M plan to tackle diabetes; full details remain unclear, but the firms aim to utilize medicine and software to offer new treatments. – Link

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s